ロード中...
Efficacy of Irinotecan as Third-line Chemotherapy for Unresectable or Recurrent Gastric Cancer
Aim: To evaluate the efficacy and safety of third-line chemotherapy (CTx) for patients with unresectable or recurrent gastric cancer (GC) refractory to S-1 with or without platinum and taxanes. Patients and Methods: We retrospectively analyzed clinicopathological and survival data of 26 patients who...
保存先:
| 出版年: | In Vivo |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Institute of Anticancer Research
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7157849/ https://ncbi.nlm.nih.gov/pubmed/32111802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11856 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|